Tag: Khiron Life Sciences
-
Around the world in 80 J’s: A narrative guide to the best growers and showers across the globe
The following is very real, first-hand account of one explorer’s exploits around the world in pursuit of the finest cannabis flowers the Earth has to offer. Never before has such a journey been attempted…until now. Mr. Phineas Choom worked at 1201 West Georgia Street, Vancouver, a building in which some of the aptest and edgiest…
-
![Khiron (KHRN.V): Why Mexican farmers are converting poppy fields to corn]()
Khiron (KHRN.V): Why Mexican farmers are converting poppy fields to corn
I have never tried opium. But I suspect I would like it. Derived from the milky sap of the poppy, the Greek poet Homer (800 BC) referred to it as “a drug to quiet all pain and strife”. Opium provides such a delicious euphoric high, that it spawned a recreational market for synthetic opioids, including…
-
Khiron Life Sciences (KHRN.V) is still the only Colombian company with revenue from legal cannabis
Khiron Life Sciences (KHRN.C) is the only Colombian cannabis company generating revenue from legal production. We checked. After the acquisition of ILANS and the launch of the cosmeceutical brand, Kuida, Khiron is in a league of its own. There is an endless stream of cannabis companies trying to establish market share in Latin America, including…
-
![Khiron (KHRN.V) expands medical cannabis network in Latin America]()
Khiron (KHRN.V) expands medical cannabis network in Latin America
Client companies come to us in a number of different ways. Sometimes because they’ve read our articles. Sometimes because they respect the journalistic chops of our boss Chris Parry. Sometimes, they’ve been referred to us by another client. Occasionally, we go to them. This is what happened late last year, when Equity Guru’s own Ethan…
-
Cannabis corner: Chemesis (CSI.C) signs $6M deal, Khiron (KHRN.V) eyes greater EU-LatAm trade and iAnthus (IAN.C) deepens Florida roots
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year lifespan, PR ONE has signed on to purchase a minimum of $300,000 of cannabis infused products and a minimum of $200,000 of flower monthly from Chemesis’…
